LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.33 | 21.74 | 1041 | 6235 | 0.1670 | 0.6062 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.33 | 21.74 | 1138 | 6235 | 0.1825 | 0.6238 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.33 | 21.74 | 1157 | 6235 | 0.1856 | 0.6271 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.30 | 21.74 | 1006 | 6244 | 0.1611 | 0.5993 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.30 | 21.74 | 1021 | 6244 | 0.1635 | 0.6022 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.30 | 21.74 | 1127 | 6244 | 0.1805 | 0.6217 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.30 | 21.74 | 1142 | 6244 | 0.1829 | 0.6243 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.27 | 21.74 | 1007 | 6201 | 0.1624 | 0.6004 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.27 | 21.74 | 1020 | 6201 | 0.1645 | 0.6029 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.27 | 21.74 | 1136 | 6201 | 0.1832 | 0.6243 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.27 | 21.74 | 1148 | 6201 | 0.1851 | 0.6263 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.24 | 21.74 | 1017 | 6162 | 0.1650 | 0.6032 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.24 | 21.74 | 1032 | 6162 | 0.1675 | 0.6061 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.24 | 21.74 | 1140 | 6162 | 0.1850 | 0.6259 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.24 | 21.74 | 1153 | 6162 | 0.1871 | 0.6281 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.21 | 21.74 | 1029 | 6235 | 0.1650 | 0.6039 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.21 | 21.74 | 1044 | 6235 | 0.1674 | 0.6068 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.21 | 21.74 | 1141 | 6235 | 0.1830 | 0.6244 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.21 | 21.74 | 1152 | 6235 | 0.1848 | 0.6263 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.18 | 21.74 | 1006 | 6114 | 0.1645 | 0.6021 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.18 | 21.74 | 1024 | 6114 | 0.1675 | 0.6056 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.18 | 21.74 | 1135 | 6114 | 0.1856 | 0.6261 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.18 | 21.74 | 1148 | 6114 | 0.1878 | 0.6283 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.15 | 21.74 | 1010 | 6167 | 0.1638 | 0.6017 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.15 | 21.74 | 1031 | 6167 | 0.1672 | 0.6058 | MN20160310_N01 | D06 |